-
5-[2-(2H5)cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate
-
ChemBase ID:
176861
-
Molecular Formular:
C20H20FNO3S
-
Molecular Mass:
373.4411032
-
Monoisotopic Mass:
373.11479273
-
SMILES and InChIs
SMILES:
c1ccc(c(c1)C(N1CCc2c(C1)cc(s2)OC(=O)C)C(=O)C1CC1)F
Canonical SMILES:
CC(=O)Oc1sc2c(c1)CN(CC2)C(c1ccccc1F)C(=O)C1CC1
InChI:
InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3
InChIKey:
DTGLZDAWLRGWQN-UHFFFAOYSA-N
-
Cite this record
CBID:176861 http://www.chembase.cn/molecule-176861.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
5-[2-(2H5)cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate
|
|
|
|
|
IUPAC Traditional name
|
|
5-[2-(2H5)cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate
|
|
|
|
|
Synonyms
|
|
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-(cyclopropyl-d5)-2-(2-fluorophenyl)ethanone
|
|
CS 747-d5
|
|
Effient-d5
|
|
LY 640315-d5
|
|
Prasugrel-d5
|
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
|
Data Source
|
Data ID
|
Price
|
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
14.248824
|
H Acceptors
|
3
|
H Donor
|
0
|
LogD (pH = 5.5)
|
4.0139766
|
LogD (pH = 7.4)
|
4.3019633
|
Log P
|
4.3072057
|
Molar Refractivity
|
96.8121 cm3
|
Polarizability
|
37.506588 Å3
|
Polar Surface Area
|
46.61 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Physical Property
Safety Information
Product Information
Bioassay(PubChem)
|
Apperance
|
|
N/A
|
Show
data source
|
|
|
Storage Condition
|
|
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
|
Show
data source
|
|
|
MSDS Link
|
|
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
P701152
|
|
A novel labelled antiplatelet agent; it is a third-generation thienopyridine. Antiplatelet agent Prasugrel showed greater platelet inhibition and decreased incidence of ischemic events than Clopidogrel but may induce increased incidence of bleeding in pat |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Von Beckerath, N., et al.: Circulation, 112, 2946 (2005)
- • Jernberg, T., et al.: Eur. Heart J., 27, 1166 (2005)
- • Farid, N., et al.: Drug Metab. Dispos., 35, 1096 (2005)
- • Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2005)
- • Jakubowski, J., et al.: J.
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent